ESC 365 - Magnetic drug targeting to vascular injury regions and atherosclerotic lesions: in vivo pilot study

ESC Premium Access

Magnetic drug targeting to vascular injury regions and atherosclerotic lesions: in vivo pilot study

Session: Poster Session 4 - Inflammation and microcirculation

Topic: Drugs, Drug Targets

Speaker: Doctor I. Cicha (Erlangen, DE)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Iwona Cicha

Friedrich Alexander University Erlangen Nuernberg, Erlangen (Germany)

1 presentation

0 follower

7 more presentations in this session

Adiponectin forms a complex with electronegative L5 LDL in human plasma and inhibits its atherogenic effects

Speaker: Professor T. Sawamura (Matsumoto, JP)

Nicotine promotes atherosclerosis development in apolipoprotein E-deficient mice through alpha 1 nicotinic acetylcholine receptor on RAW264.7 and MOVAS cells

Speaker: Mr A. Ren (Shanghai, CN)

miR-147 deficiency in macrophages exacerbates atherosclerosis in mice

Speaker: Mrs M. Nazari Jahantigh (Munich, DE)

Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice

Speaker: Doctor B. Ganbaatar (Tokushima, JP)

Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice

Speaker: Doctor R. Umezu (Fukuoka, JP)

Access the full session

Poster Session 4 - Inflammation and microcirculation

Speakers: Doctor I. Cicha, Professor T. Sawamura, Mr A. Ren, Mrs M. Nazari Jahantigh, Doctor B. Ganbaatar...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by